ENO2 and schwannoma: The S-100 protein and NSE stained positively in all Schwannomas; Vimentin presented negativity in 3 (21.4%) patients and positivity in 11 (78.6%) patients; GFAP presented negativity in 1 (33.3%) and positivity in 2 (66.6%) patients (Table 4).